| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 3e-08 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |